Business
Why the Cyclopharm (ASX:CYC) share price popped 6% today
The Cyclopharm Limited (ASX: CYC) share price was sent soaring today after the company announced a business update.
Cyclopharm shares went as high as 14.41% in afternoon trade before closing 6.78% up at $2.52 per share.
What Cyclopharm does
Cyclopharm is an ASX-listed radiopharmaceutical company headquartered in New South Wales. It currently has a market capitalisation of just over $203 million.
As stated on the company’s website, “the company’s mission is to provide nuclear medicine and other clinicians with the ability to improve patient care outcomes.”
The health company aims to achieve this objective through the provision of its core radiopharmaceutical product, Technegas, which is used in functional lung ventilation…
-
Business17 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business19 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General16 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips
-
Business16 hours agoHere’s what analysts expect for the BHP share price in the coming year